Does cagrilintide cause muscle loss?

Cagrilintide doesn't directly break down muscle — it's not catabolic in the way the question implies. But like every powerful appetite-suppressing drug, it can indirectly cost you lean mass. The mechanism is simple: cagrilintide makes you eat far less, that creates a large calorie deficit, and large deficits cost muscle unless you defend it with adequate protein and resistance training. The muscle loss, when it happens, comes from the deficit, not from the peptide itself.

Why the deficit is the real culprit

Cagrilintide is a long-acting amylin analog. Amylin is a natural satiety hormone — it slows gastric emptying and signals fullness to the brain. The whole point of the drug is to suppress appetite so you eat less and lose fat.

That's also where the risk lives. When appetite drops hard, two things tend to happen:

• You eat fewer total calories (the goal)
• You also eat less protein, often without noticing

Protein is the nutrient that protects muscle during a cut. If your appetite is suppressed and your protein quietly falls along with everything else, you've created the exact conditions for losing lean mass. The peptide didn't take your muscle — the under-eating did.

What the data does and doesn't show

Be aware of a real evidence gap here. Cagrilintide's trials (both alone and as CagriSema, the cagrilintide-plus-semaglutide combination) measured total weight loss in people with obesity, not detailed lean-vs-fat body composition in trained people lifting weights. So:

• We don't have strong DEXA data showing how much of cagrilintide's weight loss is muscle in athletes
• The "amylin may be gentler on muscle than GLP-1" idea is a mechanistic hypothesis, not a proven outcome

This isn't unique to cagrilintide — the entire GLP-1 and amylin category shares the same gap, as we cover in cagrilintide for body composition. Treat lean-mass preservation as something you have to actively manage, not something the drug guarantees.

How to protect muscle on cagrilintide

The good news is that the muscle-loss risk is largely controllable:

1. Hit a hard protein target — most lifters aim for roughly 0.7–1 g per pound of bodyweight. With appetite suppressed, this is the hardest and most important thing. Liquid protein and smaller frequent meals help.
2. Keep lifting. Resistance training is the signal that tells your body to hold onto muscle in a deficit. Don't let suppressed energy intake quietly kill your training volume.
3. Don't crash the deficit. Titrate the dose slowly rather than jumping high to lose fast. A more moderate deficit is easier to support with protein and is gentler on muscle.
4. Track performance, not just the scale. If your strength is dropping quickly, that's a warning that you're losing more than fat — ease the deficit.

How it compares to other fat-loss tools

The muscle-loss risk on cagrilintide isn't worse than its cousins — it's roughly the same category-wide problem that comes with any drug whose main effect is suppressing appetite:

In every case the drug isn't catabolic — the under-eating is. So the defense is the same across all of them: protein and resistance training. The one nuance often claimed for cagrilintide is that amylin's satiety signal may feel more "physiological" and produce a more moderate deficit than aggressive high-dose GLP-1. That might make it slightly easier to eat enough protein, but it's a hypothesis, not a proven muscle-sparing advantage. Don't let it lull you into skipping the protein math.

The bottom line

Cagrilintide won't melt your muscle on its own, but it can absolutely contribute to losing it if you let appetite suppression drive your protein and training into the ground. Used deliberately — slow titration, high protein, consistent lifting — it's a fat-loss tool that can preserve most of your hard-earned muscle. Used carelessly, it's a fast way to get smaller everywhere. The peptide sets the appetite; you decide what gets lost.

Related questions

• Can peptides cause weight gain?
• Should I use peptides during a cut?
• Cutting with peptides: what works